Increase in Pharmaceutical Production Drives Growth

DUBLIN, May 23, 2023 /PRNewswire/ — The “Flowmeter Global Market Report 2023” report has been added to  ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global flowmeter market grew from $8.13 billion in 2022 to $8.93 billion in 2023 at a compound … Read more

a ferramenta de IA supera os atendentes humanos de chamadas de emergência na identificação de AVCs, segundo novo estudo

MUNIQUE, 23 de maio de 2023 /PRNewswire/ — Pesquisadores da Dinamarca desenvolveram uma nova estrutura de inteligência artificial (IA) para lidar com o número de acidentes vasculares cerebrais (AVCs) que passam despercebidos pelos atendentes humanos de chamadas de emergência. A estrutura superou os atendentes de chamadas de emergência no reconhecimento de AVCs para ambos os sexos … Read more

FDA Roundup: May 23, 2023

SILVER SPRING, Md., May 23, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA and the Veterans Health Administration announced a new collaboration to jointly develop emergency preparedness and response tools and protocols intended to help increase medical product … Read more

UCB y Veeva colaboran para mejorar la experiencia de los pacientes en los ensayos clínicos

Las empresas colaboran para establecer un nuevo estándar de ensayos clínicos digitales centrados en el paciente BRUSELAS y PLEASANTON, California, 23 de mayo de 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) y UCB, una compañía biofarmacéutica global, han anunciado hoy una colaboración que se centrará en soluciones tecnológicas dirigidas a mejorar la experiencia del paciente y la eficiencia … Read more

Waters Corporation to Present at the Jefferies 2023 Healthcare Conference

MILFORD, Mass., May 23, 2023 /PRNewswire/ — Waters Corporation (NYSE:WAT) announced that Udit Batra Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference in New York City on Thursday, June 8th, 2023 at 9:30AM Eastern Time. A live webcast of the event will be available on the ‘Events … Read more

Cincinnati Children’s named one of nation’s Best Employers for New Grads by Forbes

CINCINNATI, May 23, 2023 /PRNewswire/ — Cincinnati Children’s has again been named one of America’s Best Employers for New Grads by Forbes, and this year ranks among the Top 10 health systems in the nation.  Of the 300 companies recognized by Forbes for 2023, Cincinnati Children’s ranked No. 34 among the Best Employers for New … Read more

Parents–Talk With Your High School Grads About Celebrating Safely

BETHESDA, Md., May 23, 2023 /PRNewswire/ — GraduationBefore your high school graduate celebrates, talk with them about keeping events alcohol–free. It may save a life! Drinking to celebrate graduation can result in vandalism, arrests, sexual assaults, injuries and trips to the emergency room, alcohol-related traffic crashes, and worse.  Tweet this NIH Graphic No amount of … Read more

High Conflict Divorce Coach Certification Program Announces 2024 Dates

The High Conflict Divorce Coach Certification Program (HCDCCP) announces the program dates for 2024, with limited spots still available for the August 2023 session. SAN LUIS OBISPO, Calif., May 23, 2023 /PRNewswire/ — The High Conflict Divorce Coach Certification Program (HCDCCP) has announced the dates for 2024: Winter 2024 Session (January 22, 2024 – March … Read more

Abbott Unveils Late-Breaking Data Showing the World’s First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints

Abbott’s AVEIR™ DR i2i™ IDE study is the industry’s first prospective study on the safety and performance of the world’s first dual-chamber leadless pacemaker The study successfully met all three of its primary safety and performance endpoints Abbott’s investigational AVEIR DR leadless pacemakers have been submitted for evaluation by the U.S. FDA NEW ORLEANS, May … Read more

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Chinook To Contact Him Directly To Discuss Their Options

NEW YORK, May 20, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Chinook Therapeutics, Inc. (“Chinook” or the “Company”) (NASDAQ: KDNY). If you suffered losses exceeding $50,000 investing in Chinook stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner … Read more